Myasthenia gravis. History, clinical features, pathogenesis and etiology
Somnier, F.E.
Ugeskrift for Laeger 146(5): 340-344
1984
ISSN/ISBN: 0041-5782 PMID: 6719607 Document Number: 227610
Document emailed within 1 workday
Related Documents
Sri-udomkajorn, S.; Panichai, P.; Liumsuwan, S. 2011: Childhood myasthenia gravis: clinical features and outcomes Journal of the Medical Association of Thailand 94(Suppl 3): S152-S157Liu, W.-b.; He, J.-z.; Yao, X.-l.; Huang, R.-x. 2004: The clinical features of myasthenia gravis affecting nonskeleton muscles Zhonghua Nei Ke Za Zhi 43(8): 588-590
Chan, M.K.; Britton, M. 1980: Comparative clinical features in patients with myasthenia gravis with systemic lupus erythematosus Journal of Rheumatology 7(6): 838-842
Téllez Zenteno, J.F.; Morales Buenrostro, L.E.; Torre Delgadillo, A. 2000: Pathogenesis of myasthenia gravis Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 52(1): 80-85
Nakata, T. 1975: History of myasthenia gravis Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1961-1971
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
Sher, E.; Gotti, C.; Clementi, F. 1988: Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis Annali Dell'istituto Superiore di Sanita 24(1): 103-116
Gieron, M.A.; Korthals, J.K.; Lewis, J.A. 1987: Lambert-Eaton myasthenic syndrome associated with hypothyroidism and features of myasthenia gravis Journal of the Florida Medical Association 74(5): 336-338
Maev, I.V.; Orlov, L.L.; Nefedova, I.V. 1997: Erosive lesions of gastroduodenal mucosa: etiology, pathogenesis, clinical features, treatment Klinicheskaia Meditsina 75(6): 57-61
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
de Assis, J.L. 1994: History of the study of myasthenia gravis at the Neurologic Clinic of the Hospital of Medical School Clinics of the University of São Paulo Arquivos de Neuro-Psiquiatria 52(3): 376-385
Hugon, J.; Ludolph, A.; Roy, D.N.; Schaumburg, H.H.; Spencer, P.S. 1988: Studies on the etiology and pathogenesis of motor neuron diseases. II. Clinical and electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus and IDPN Neurology 38(3): 435-442
Matsumoto, R.; Motomura, M.; Yoshimura, T.; Kohara, N.; Kato, T. 1999: Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy Rinsho Shinkeigaku 39(5): 531-537
Saha, S.P.; Mukherjee, S.; Das, S.K.; Ganguly, P.K.; Roy, T.N.; Maiti, B.; Bhattacharya, S.; Sarkar, S. 1998: Clinical profile of myasthenia gravis Journal of the Association of Physicians of India 46(11): 933-936
De Crousaz, G. 1979: Myasthenia gravis: clinical studies of 50 patients Revue Medicale de la Suisse Romande 99(5): 277-283
Masaoka, A.; Maeda, M.; Monden, Y.; Nakahara, K.; Kotake, Y. 1976: Clinical results following thymectomy in myasthenia gravis Medical Journal of Osaka University 26(3-4): 117-129
Hamaguchi, Y.; Iwnami, S.; Nakamura, M.; Fukushima, K.; Nagashima, H. 1985: Clinical trial of atracurium besylate for a patient with myasthenia gravis Masui. Japanese Journal of Anesthesiology 34(9): 1275-1279
Wakata, N.; Kawamura, Y.; Shin, K.; Kobayashi, T.; Kinoshita, M. 1991: Clinical analysis of myasthenia gravis accompanied by invasive thymoma Rinsho Shinkeigaku 31(3): 260-265
Apostolski, S.; Krstić, S.; Gospavić, J.; Miletić, V.; Lazić, D.; Stolić, I. 1985: Clinical, pathologic and HLA antigen markers of heterogeneity associated with myasthenia gravis Neurologija 34(1-4): 47-58
Jurenić, D.; Jusić, A. 1978: Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication) Neurologija 26(1-4): 37-39